295 related articles for article (PubMed ID: 20577707)
1. [Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010].
Stangel M; Gold R
Nervenarzt; 2011 Apr; 82(4):415-6, 418, 420 passim. PubMed ID: 20577707
[TBL] [Abstract][Full Text] [Related]
2. [The use of intravenous immunoglobulins in neurology].
Stojkovic T; Dubucquoi S
Rev Neurol (Paris); 2005 Sep; 161(8-9):781-94. PubMed ID: 16244560
[TBL] [Abstract][Full Text] [Related]
3. [Use of high dose intravenous immunoglobulin in neurologic disease].
Korsak J; Zaleska B; Orłowska E; Kotowicz J
Pol Merkur Lekarski; 2005 Jul; 19(109):98-101. PubMed ID: 16194039
[TBL] [Abstract][Full Text] [Related]
4. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin in neurology--mode of action and clinical efficacy.
Lünemann JD; Nimmerjahn F; Dalakas MC
Nat Rev Neurol; 2015 Feb; 11(2):80-9. PubMed ID: 25561275
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS;
Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854
[TBL] [Abstract][Full Text] [Related]
7. Can we face the challenge of expanding use of intravenous immunoglobulin in neurology?
Elovaara I; Hietaharju A
Acta Neurol Scand; 2010 Nov; 122(5):309-15. PubMed ID: 20085560
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin treatment of neurological autoimmune diseases.
Stangel M; Hartung HP; Marx P; Gold R
J Neurol Sci; 1998 Jan; 153(2):203-14. PubMed ID: 9511879
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy.
van Doorn PA
J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):38-42. PubMed ID: 7964851
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Patwa HS; Chaudhry V; Katzberg H; Rae-Grant AD; So YT
Neurology; 2012 Mar; 78(13):1009-15. PubMed ID: 22454268
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Tolerability of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin in Neurologic Diseases.
Chen Y; Wang C; Xu F; Ming F; Zhang H
Clin Ther; 2019 Oct; 41(10):2112-2136. PubMed ID: 31445679
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
Nobile-Orazio E; Cocito D; Jann S; Uncini A; Beghi E; Messina P; Antonini G; Fazio R; Gallia F; Schenone A; Francia A; Pareyson D; Santoro L; Tamburin S; Macchia R; Cavaletti G; Giannini F; Sabatelli M;
Lancet Neurol; 2012 Jun; 11(6):493-502. PubMed ID: 22578914
[TBL] [Abstract][Full Text] [Related]
13. Guidelines on the use of intravenous immune globulin for neurologic conditions.
Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L
Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immune globulin therapy for neurologic diseases.
Dalakas MC
Ann Intern Med; 1997 May; 126(9):721-30. PubMed ID: 9139559
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and availability of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy].
Iijima M; Koike H; Sobue G
Nihon Rinsho; 2012 Apr; 70(4):715-21. PubMed ID: 22568158
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial.
Hughes RA
Expert Rev Neurother; 2009 Jun; 9(6):789-95. PubMed ID: 19496683
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
Lopate G; Pestronk A; Al-Lozi M
Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis.
Dudesek A; Zettl UK
J Neurol; 2006 Sep; 253 Suppl 5():V50-8. PubMed ID: 16998754
[TBL] [Abstract][Full Text] [Related]
19. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of high infusion rate IVIG in CIDP.
Jiang Y; Mendoza M; Sarpong E; Mannan S; Ng E; Katzberg H; Bril V; Barnett C
Muscle Nerve; 2020 Nov; 62(5):637-641. PubMed ID: 32785949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
